Perretti, Mauro http://orcid.org/0000-0003-2068-3331
Article History
First Online: 30 November 2020
Competing interests
: M.P. declares that he is on the Scientific Advisory Board of Antibe Therapeutics. He also consults for Bristol Meyers Squibb, Palatin Technologies and SynAct Pharma AS and is a founding member of Resolomics Ltd and a shareholder of ResoTher Pharma AS.